Table 2.
1-year AF recurrence composite outcomes for patients
| Patients | Events | Adjusted OR (95% CI)∗ | |
|---|---|---|---|
| Average impedance drop | |||
| High: >8.05 Ω | 80 | 10 (12.5) | Reference |
| Medium: 6.47–8.05 Ω | 81 | 17 (21.0) | 1.80 (0.57–5.98) |
| Low: ≤6.47 Ω | 81 | 30 (37.0) | 5.91 (1.81–21.8) |
| Right WACA impedance drops∗ | |||
| High: >8.05 Ω | 74 | 10 (13.5) | Reference |
| Medium: 6.47–8.05 Ω | 61 | 6 (9.8) | 0.44 (0.09–1.79) |
| Low: ≤6.47 Ω | 107 | 41 (38.3) | 3.80 (1.23–13.0) |
| Left WACA impedance drop∗ | |||
| High: >8.05 Ω | 100 | 14 (14.0) | Reference |
| Medium: 6.47–8.05 Ω | 75 | 18 (24.0) | 1.50 (0.57–3.98) |
| Low: ≤6.47 Ω | 67 | 25 (37.3%) | 4.48 (1.57–13.5) |
Values are n or n (%), unless otherwise indicated. The composite outcome includes AF hospitalization, repeat ablation, direct current cardioversion, and initialization of a new antiarrhythmic drug post–blanking period.
AF = atrial fibrillation; CI = confidence interval; OR = odds ratio; WACA = wide antral circumferential ablation.
The full results of multivariable are presented in the Supplemental Tables 1–3.